A Computational DFT Study of the Stereoinversion of Succinimide Residues Formed in Proteins and Peptides Catalyzed by a Hydrogen Phosphate Ion: An Unsymmetrical SE1 Mechanism
被引:0
|
作者:
Takahashi, Ohgi
论文数: 0引用数: 0
h-index: 0
机构:
Shonan Univ Med Sci, Fac Pharmaceut Sci, 16-10 Kamishinano,Totsuka ku, Yokohama 2440806, JapanShonan Univ Med Sci, Fac Pharmaceut Sci, 16-10 Kamishinano,Totsuka ku, Yokohama 2440806, Japan
Takahashi, Ohgi
[1
]
机构:
[1] Shonan Univ Med Sci, Fac Pharmaceut Sci, 16-10 Kamishinano,Totsuka ku, Yokohama 2440806, Japan
Succinimide residues formed spontaneously from aspartic acid (Asp) and asparagine (Asn) residues in proteins and peptides are stereochemically unstable, undergoing partial l-to-d stereoinversion, and this is responsible for the d-Asp and d-beta-Asp residues found in long-lived proteins. These stereoinverted abnormal amino acid residues are believed to be related to aging and some age-related diseases such as cataracts. Although the succinimide stereoinversion is nonenzymatic, a catalyst is required for it to occur at physiological temperature. In this study, it was found by density functional theory (DFT) calculations that a hydrogen phosphate ion (HPO42-) can effectively catalyze the stereoinversion of the succinimide intermediate. The HPO42- ion abstracts a proton from the asymmetric carbon atom of the succinimide residue to form an enolate intermediate. Then, while the resultant dihydrogen phosphate ion (H2PO4-) remains bound to the enolate ion, a water molecule donates a proton to the enolate intermediate on the opposite side from the phosphate (which is the rate-determining step) to produce the inverted carbon atom. The calculated activation barrier (ca. 90 kJ mol-1) is consistent with a slow in vivo reaction. The present found mechanism can be termed the "unsymmetrical SE1" or "pseudo-SE2" mechanism.
机构:
Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, JapanTohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan
Takahashi, Ohgi
Kirikoshi, Ryota
论文数: 0引用数: 0
h-index: 0
机构:
Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, JapanTohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan
Kirikoshi, Ryota
Manabe, Noriyoshi
论文数: 0引用数: 0
h-index: 0
机构:
Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, JapanTohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan
Manabe, Noriyoshi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,
2016,
17
(10):
机构:
Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, JapanTohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan
Kirikoshi, Ryota
Manabe, Noriyoshi
论文数: 0引用数: 0
h-index: 0
机构:
Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, JapanTohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan
Manabe, Noriyoshi
Takahashi, Ohgi
论文数: 0引用数: 0
h-index: 0
机构:
Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, JapanTohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan